WOCKPHARMA — Wockhardt Balance Sheet
0.000.00%
- IN₹218.18bn
- IN₹236.09bn
- IN₹30.12bn
- 24
- 10
- 70
- 22
Annual balance sheet for Wockhardt, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 2,326 | 3,810 | 900 | 5,050 | 5,340 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 9,896 | 11,970 | 10,640 | 8,570 | 10,290 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 24,244 | 25,890 | 22,080 | 21,840 | 25,690 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 29,143 | 28,600 | 24,360 | 23,090 | 22,310 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 77,727 | 82,430 | 76,830 | 76,490 | 81,350 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 31,182 | 32,070 | 34,350 | 27,910 | 20,420 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 43,959 | 43,940 | 43,290 | 42,900 | 37,820 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 33,768 | 38,490 | 33,540 | 33,590 | 43,530 |
| Total Liabilities & Shareholders' Equity | 77,727 | 82,430 | 76,830 | 76,490 | 81,350 |
| Total Common Shares Outstanding |